MIPASETAMAB
UNII DCI3L5GHC9

Substance Identification & Data

This profile provides standardized clinical and technical data for Mipasetamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DCI3L5GHC9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2361055-48-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

DCI3L5GHC9

CAS Registry Number

2361055-48-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MIPASETAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C175822

National Cancer Institute reference terminology for clinical and research data.

INN ID

11483

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-249

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Mipasetamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MIPASETAMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR TYROSINE KINASE AXL) (HUMAN-MUS MUSCULUS MONOCLONAL 1H12 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL 1H12 .KAPPA.-CHAIN, DIMER, 302,302'-BIS(N-(O-2-(ACETYLAMINO)-6-AZIDO-2,6-DIDEOXY-.BETA.-D-GALACTOPYRANOSYL-(1->4)-O-(6-DEOXY-.ALPHA.-L-GALACTOPYRANOSYL-(1->6))-2-(ACETYLAMINO)-2-DEOXY-.BETA.-D-GLUCOPYRANOSYL)-L-ASPARAGINE)

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS AXL (AXL RECEPTOR TYROSINE KINASE, TYROSINE-PROTEIN KINASE RECEPTOR UFO)), HUMANIZED MONOCLONAL ANTIBODY (MIPASETAMAB)

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TYROSINE-PROTEIN KINASE RECEPTOR UFO (AXL ONCOGENE; EC=2.7.10.1)); HUMANIZED MONOCLONAL ANTIBODY; .GAMMA.1 HEAVY CHAIN HUMANIZED (1-451) (VH HUMANIZED (HOMO SAPIENS IGHV3-30*03 (93%)-(IGHD)-IGHJ4*01 (92%)) (8.8.15) (1-122) HOMO SAPIENS IGHG1*03 (CH1(R97>K(219)), CH3(K107>DEL(452))) (123-451)), (225-215')-DISULFIDE WITH .KAPPA. LIGHT CHAIN HUMANIZED (1'-215') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV3-11*01 (84%)-IGKJ4*01 (91%))(7.3.9) (1'-108')-HOMO SAPIENS IGKC*01 (109'-215')); DIMER (231-231'':234-234'')-BISDISULFIDE, PRODUCED IN CHINESE CHO CELLS, GLYCOFORM ALFA

MIPASETAMAB [INN]

MIPASETAMAB [USAN]